new_0222_0301|OLMA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0301|OLMA|1|Olema Pharmaceuticals inc Total Current Assets (Quarterly) (USD)|Olema Pharmaceuticals inc Cash and Short Term Investments (Quarterly) (USD)|Olema Pharmaceuticals inc Inventories (Quarterly) (USD)|Olema Pharmaceuticals inc Net PP&E (Quarterly) (USD)|Olema Pharmaceuticals inc Goodwill and Intangibles (Quarterly) (USD)|Olema Pharmaceuticals inc Total Liabilities (Quarterly) (USD)|Olema Pharmaceuticals inc Total Current Liabilities (Quarterly) (USD)|Olema Pharmaceuticals inc Total Long Term Liabilities (Quarterly) (USD)|Olema Pharmaceuticals inc Total Deposits (Quarterly) (USD)|Olema Pharmaceuticals inc Book Value (Quarterly) (USD)|Olema Pharmaceuticals inc Retained Earnings (Quarterly) (USD)|Olema Pharmaceuticals inc Treasury Stock (Quarterly) (USD)|Olema Pharmaceuticals inc EV to Revenues|Olema Pharmaceuticals inc EV to Earnings|Olema Pharmaceuticals inc EV to Free Cash Flow|Olema Pharmaceuticals inc EV to Assets (Quarterly)|Olema Pharmaceuticals inc PS Ratio|Olema Pharmaceuticals inc PE Ratio|Olema Pharmaceuticals inc Price to Book Value|Olema Pharmaceuticals inc PEG Ratio|Olema Pharmaceuticals inc Debt to Equity Ratio|Olema Pharmaceuticals inc Dividend Yield|Olema Pharmaceuticals inc Shareholder Yield (TTM)|Olema Pharmaceuticals inc Percent of Shares Outstanding Short|Olema Pharmaceuticals inc Total Receivables (Quarterly) (USD)|Olema Pharmaceuticals inc Total Payables (Quarterly) (USD)|Olema Pharmaceuticals inc Total Capital Stock (Quarterly) (USD)|Olema Pharmaceuticals inc Return on Invested Capital|Olema Pharmaceuticals inc Quality Ratio Score|Olema Pharmaceuticals inc Momentum Score|Olema Pharmaceuticals inc Beta (1Y)|Olema Pharmaceuticals inc Sustainable Growth Rate (TTM)|Olema Pharmaceuticals inc Institutional Investor Ownership Percentage|Olema Pharmaceuticals inc Average Diluted Shares Outstanding (Quarterly)|Olema Pharmaceuticals inc Total Employees (Annual)|Olema Pharmaceuticals inc EPS Diluted (Quarterly) (USD)|Olema Pharmaceuticals inc Shares Outstanding|Olema Pharmaceuticals inc Repurchase of Capital Stock (Quarterly) (USD)|Olema Pharmaceuticals inc Ordinary Shares Number (Quarterly)|Olema Pharmaceuticals inc Payout Ratio|Olema Pharmaceuticals inc Quick Ratio (Quarterly)|Olema Pharmaceuticals inc Normalized Diluted EPS (Quarterly) (USD)|Olema Pharmaceuticals inc Stock Buybacks (Quarterly) (USD)|Olema Pharmaceuticals inc Effective Tax Rate (TTM)|Olema Pharmaceuticals inc Return on Equity|Olema Pharmaceuticals inc Net Income (TTM) (USD)|Olema Pharmaceuticals inc Revenue (TTM) (USD)|Olema Pharmaceuticals inc Dividend Per Share (Quarterly) (USD)|Olema Pharmaceuticals inc Revenue (Quarterly) (USD)|Olema Pharmaceuticals inc Gross Profit (Quarterly) (USD)|Olema Pharmaceuticals inc SG&A Expense (Quarterly) (USD)|Olema Pharmaceuticals inc Pre-Tax Income (Quarterly) (USD)|Olema Pharmaceuticals inc Net Income (Quarterly) (USD)|Olema Pharmaceuticals inc Net Interest Income (Quarterly) (USD)|Olema Pharmaceuticals inc Price (USD)|Olema Pharmaceuticals inc Total Return Price (USD)|Olema Pharmaceuticals inc Enterprise Value (USD)|Olema Pharmaceuticals inc 30-Day Average Daily Volume|Olema Pharmaceuticals inc 1 Year Price Returns (Daily)||
new_0222_0301|OLMA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0301|OLMA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0301|OLMA|5|127.8|127.8|0|127.8|0|127.8|127.8|127.8|0|127.8|127.8|0|0|0|1.44912280702|0|0|0|1.45222929936|0|0|1.45367412141|0|15.25|0|127.8|127.8|0|0|31|31|0|0|91.2857142857|45|91.2857142857|32.1818181818|91.25|127.8|0|0|91.2857142857|0|0|0|91.25|0|0|0|0|91.2857142857|91.2857142857|91.2857142857|91.2857142857|1.45222929936|1.45222929936|1.45367412141|1.44014084507|1.47540983607||
new_0222_0301|OLMA|6|5|5|0|5|0|5|5|5|0|5|5|0|0|0|285|0|0|0|314|0|0|313|0|28|0|5|5|0|0|1|2|0|0|7|1|7|11|4|5|0|0|7|0|0|0|4|0|0|0|0|7|7|7|7|314|314|313|284|61||
new_0222_0301|OLMA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0301|OLMA|201912|0.103|0.068||0.026||10.726|1.378|9.348||-10.594|-10.762|||||||||||||||0.935|0|||||||14.0986||-0.0721|||37.5197|||-0.0721|||||||||0.107|-1.017|-1.017|0|||||||
new_0222_0301|OLMA|202003||||||||||||||||||||||||||||||||||14.0986||-0.1201||||||-0.1201|||||||||0.248|-1.693|-1.693|-0.65|||||||
new_0222_0301|OLMA|202006||||||||||||||||||||||||||||||||||14.0986||-0.174||||||-0.174|||||||||0.539|-2.453|-2.453|0.033|||||||
new_0222_0301|OLMA|202009|129.087|127.824||0.024||5.273|5.273|0||125.41|-22.963||||||||15.8552|||0||1.0918||0.097|0.003||||||25.7919|37.5197|22|-0.2589|40.1697|-2.289|39.3082|||-0.2091||||-13.007|||||3.195|-7.844|-7.844|0.023|49.5|49.5|1860.5762||||
new_0222_0301|OLMA|202012|342.137|338.549||0.075||4.585|4.585|0||338.137|-33.094||||-77.8732||||14.9776|||0||1.8086||1.361|0.003|||||||39.3082|37|-0.5|39.3082|0|39.3082|||-0.5||||-22.121|||||3.842|-10.131|-10.131|0.001|46.76|46.76|1750.5112|229635.7||48.73|43.82
new_0222_0301|OLMA|202103|330.265|326.968||0.526||5.277|5.277|0||326.024|-48.433||||-34.3521||||3.3619|||0||2.1434||0.49|0.003|||||||39.3258||-0.39|40.1697||40.1697|||-0.39||||-35.767|||||4.758|-15.339|-15.339|0.111|28.92|28.92|798.2441|220430.5||31.5|24.9
new_0222_0301|OLMA|202106|320.854|318.144||0.866||8.146|8.146|0||314.084|-64.839||||-21.107||||3.4474|||0||5.7068||0.452|0.003|||||||39.4153||-0.42|39.5526||39.5526|||-0.42||||-49.72|||||4.612|-16.406|-16.406|0.117|27.98|27.98|796.9802|281899.6333||22.96|29.92
new_0222_0301|OLMA|202109|308.28|305.954||0.975||8.901|8.901|0||300.894|-82.552||||-18.7418||||3.6915|||0||6.0811||0.373|0.003||||1.7402|||39.6077||-0.45|39.6813|0|39.6813|||-0.45||||-59.589|||||5.239|-17.713|-17.713|0.105|29.31|29.31|841.2951|364130.2667|-82.8431|27.09|8.75
new_0222_0301|OLMA|202112||287.25||||11.377|||||||||-1.6927||||1.2787|||0||9.5204||||||1|1.9879|||||-0.54|39.7973|||||||||-71.096|||||5.782||-21.638||9.55|9.55|78.7926|1330262.6667|-80.5324|6.15|4.31
new_0222_0301|OLMA|202203||267.867||||12.328|||||||||||||0.6438|||||||||||||||||-0.58|39.8693|||||||||-78.787|||||7.245||-23.03||4.54|4.54|-104.0483|404745.6||2.78|2.86
new_0222_0301|OLMA|202206||240.711||||14.317|||||||||||||0.7017|||||||||||||||||-0.82|39.9745|||||||||-95.239|||||6.239||-32.858||4.61|4.61|-81.8406|604540.2333||5.01|3.95
new_0222_0301|OLMA|202209||222.6||||14.298|||||||||||||0.5064|||||||||||||||||-0.57|40.0846|||||||||-100.246|||||5.595||-22.72||2.96|2.96|-121.069|195584.7333||3.75|2.87
new_0222_0301|OLMA|202212||204.421||||18.099|||||||||||||0.4534|||||||||||||||||-0.65|40.2871|||||||||-104.787|||||5.635||-26.179||2.44|2.44|-123.8888|123114.6||4.96|4.56
new_0222_0301|OLMA|202303||185.954||||20.793|||||||||||||0.7466|||||||||||||||||-0.7|40.4383|||||||||-110.043|||||6.776||-28.286||3.63|3.63|-56.9279|78655.4||4.34|5.17
new_0222_0301|OLMA|202306||167.444||||16.041|||||||||||||2.248|||||||||||||||||-0.49|41.1225|||||||||-97.28|||||3.612||-20.095||9.65|9.65|207.3964|438377.6333||8.78|9.33
new_0222_0301|OLMA|202309||276.901||||17.665|||||||||||||4.3561|||||||||||||||||-0.48|54.6015||||||-129.76|||-96.062|||||3.889||-21.502||12.9|12.9|536.429|281976.7667||12.35|13.18
new_0222_0301|OLMA|202312||261.807||||23.05|||||||||||||2.8964|||||||||||||||||-0.48|54.9928||||||0.024|||-96.655|||||4.544||-26.772||14.55|14.55|519.9996|1181548.9||13.04|12.97
new_0222_0301|OLMA|202403||248.977||||27.376|||||||||||||2.4666|||||||||||||||||-0.56|55.8679||||||-7.901|||-99.339|||||4.456||-30.97||11.2|11.2|364.4376|951933.9||10.15|9.65
new_0222_0301|OLMA|202406||239.104||||27.394|||||||||||||2.6533|||||||||||||||||-0.54|57.2464||||||-14.886|||-109.626|||||4.421||-30.382||11.21|11.21|378.0409|1194883.2333||15.43|11.8
new_0222_0301|OLMA|202409||214.763||||31.262|||||||||||||3.073|||||||||||||||||-0.6|57.2883|||||||||-122.679|||||4.395||-34.555||12.19|12.19|458.9734|572371.0667||11.55|10.12
new_0222_0301|OLMA|202412||434.086||||42.015|||||||||||||2.2955|||||||||||||||||-0.4|74.3126||||||-243.501|||-129.474|||||4.469||-33.567||6.15|6.15|241.8345|996542.4333||6.11|4.37
new_0222_0301|OLMA|202503||392.707||||26.187|||||||||||||0.6867|||||||||||||||||-0.36|68.3331|||||||||-128.893|||||4.249||-30.389||4.11|4.11|-153.237|916830.3||4.89|5.15
new_0222_0301|OLMA|202506|||||||||||||||||||0.8369||||||||||||||||||||||||||||||||||||4.69|4.69|-71.8111|792991.3||4.57|